ABK Biomedical Secures US$35 Million Series D Financing to Advance Liver Cancer Treatment
Halifax-based medical device company ABK Biomedical, Inc. (“ABK Biomedical”) has raised US$35M in Series D financing to support the commercialization of its innovative liver cancer treatment.Founded…